Sheer Health Company Assists Patients with Insurance Claim Denials
A company named Sheer Health helps patients navigate denials of health insurance claims. Seventy-three percent of Americans view delays and denials in medical treatment by insurers as a major problem. The service reviews policies and appeals decisions on behalf of clients for a fee.
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)A survey indicates that 73 percent of Americans consider delays and denials of medical treatment by health insurance companies to be a major problem. Sheer Health, a company founded to address these issues, assists clients in appealing insurance decisions. Co-founders reported that 20 percent of insurance claims are denied.
Mathew Evins, a marketing executive, experienced chronic back pain for eight years. By 2024, his condition made walking difficult, and his doctors recommended surgery after non-invasive treatments failed. His insurance company required additional physical therapy and denied coverage multiple times over seven months, leading to deterioration in his condition.
Evins described the process as emotionally challenging and physically painful. Doctors warned that delaying surgery could cause permanent damage. He noted that 27 million Americans lack health insurance, but his experience highlighted issues even for those who are insured.
Health's Services Patients can take a picture of their bill and upload it to Sheer Health.
The company then handles all aspects of appealing denials to the insurance provider. Services are available for $40 per month or a percentage of recovered funds if the appeal succeeds. A co-founder stated that the goal is for people to never have to deal with their health insurance again.
This resulted in approval, and Evins underwent surgery in mid-October 2024.
Hempstead, senior policy officer at the Robert Wood Johnson Foundation in Princeton, New Jersey, discussed common experiences with denials.
She cited an example of a patient denied coverage for Botox treatments for migraines after previously benefiting from them. Hempstead authored the book 'Uncovered: The Story of Insurance in America,' published by Oxford University Press. Hempstead stated that providers aim to deliver treatments they deem helpful, while insurers act as intermediaries in coverage decisions.
She noted that the need for services like Sheer Health indicates broader challenges in the health care system. Evins emphasized that insurance companies should have a voice in coverage, but they shouldn't have the definitive voice.
AHIP stated that health plans, providers, and drugmakers share responsibility for making high-quality care affordable and easier to navigate. Following approval, Evins reported improved health after his surgery.
Key Facts
Story Timeline
3 events- Mid-October 2024
Mathew Evins underwent back surgery after Sheer Health resolved his insurance denial.
1 sourceCbs News - 2024
Mathew Evins's back condition worsened, leading to repeated insurance denials over seven months.
1 sourceCbs News - Prior to 2024
Jeff Witten and Ben Howard co-founded Sheer Health to address 20 percent claim denial rate.
1 sourceCbs News
Potential Impact
- 01
Individuals with denied claims might experience faster access to recommended treatments.
- 02
More patients may use services like Sheer Health to appeal denials, potentially increasing approval rates.
- 03
Insurance companies could face higher volumes of appeals, affecting processing times.
- 04
Health care system discussions may focus more on intermediary roles of insurers.
Transparency Panel
Related Stories
The TimesTrump Nominates Dr. Nicole Saphier for Surgeon General After Previous Nominee Withdraws
President Trump announced Dr. Nicole Saphier, a 44-year-old radiologist and Fox News contributor, as his nominee for U.S. surgeon general on Thursday, following the withdrawal of Dr. Casey Means due to insufficient Senate support. Saphier, who authored a book titled Make America…
Usa TodaySupreme Court Considers Cancer Warning Requirement for Monsanto's Roundup
The U.S. Supreme Court heard arguments on whether Monsanto must add a cancer warning to its Roundup weedkiller, following a $1.25 million verdict awarded to plaintiff John Durnell. The case examines if federal EPA regulations preempt state court lawsuits over labeling. The Trump…
StatNancy Cox, Former CDC Influenza Division Leader, Dies at 77 from Glioblastoma
Nancy Cox, who led the CDC's influenza team for 22 years and contributed to global flu surveillance, died Thursday from glioblastoma. She was 77. Colleagues praised her role in pandemic preparedness and vaccine development.